Panacos Pharmaceuticals
(OTC) PANC
Panacos Pharmaceuticals Financials at a Glance
Market Cap
$100
Revenue (TTM)
$99.00K
Net Income (TTM)
$35.76M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
143.12 (High)
Dividend
$0.00
Beta (Volatility)
143.12 (High)
Price
$0.00
Volume
120
Open
$0.00
Price
$0.00
Volume
120
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
143.12 (High)
Price
$0.00
Volume
120
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
PANC News
So-So Results From Panacos
Making Cents in Penny Stocks
Better Late Than Never for Panacos
Stop Dragging, Panacos
The CEO Who Battles HIV
Panacos' Plans
Get Ready for the Bounce
Panacos Validates Itself
PANC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Panacos Pharmaceuticals
PANC Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
217%
Net Income Margin
-208%
Return on Equity
0%
Return on Capital
85%
Return on Assets
-67%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.00
Shares Outstanding
53.64M
Volume
120
Short Interest
0.00%
Avg. Volume
2
Financials (TTM)
Gross Profit
$180.00K
Operating Income
$39.02M
EBITDA
$38.23M
Operating Cash Flow
$31.04M
Capital Expenditure
$48.00K
Free Cash Flow
$31.08M
Cash & ST Invst.
$51.90M
Total Debt
$19.31M
Panacos Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$24.00K
-20.0%
Gross Profit
$24.00K
-20.0%
Gross Margin
100.00%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$2.44
N/A
Employees
41
N/A
Net Income
$8.15M
-3.0%
EBITDA
$7.26M
+10.3%
Quarterly Fundamentals
Net Cash
$8.68M
-77.9%
Accounts Receivable
$101.00K
-24.6%
Inventory
$0.00
N/A
Long Term Debt
$11.15M
+27.2%
Short Term Debt
$7.05M
+12275.4%
Return on Assets
-67.24%
N/A
Return on Invested Capital
84.82%
N/A
Free Cash Flow
$7.80M
-12.2%
Operating Cash Flow
$7.80M
-12.2%